193 related articles for article (PubMed ID: 17681748)
1. Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Holson RR; Freshwater L; Maurissen JP; Moser VC; Phang W
Neurotoxicol Teratol; 2008; 30(4):326-48. PubMed ID: 17681748
[TBL] [Abstract][Full Text] [Related]
2. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.
Crofton KM; Makris SL; Sette WF; Mendez E; Raffaele KC
Neurotoxicol Teratol; 2004; 26(3):345-52. PubMed ID: 15113596
[TBL] [Abstract][Full Text] [Related]
3. Identification and interpretation of developmental neurotoxicity effects: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Tyl RW; Crofton K; Moretto A; Moser V; Sheets LP; Sobotka TJ
Neurotoxicol Teratol; 2008; 30(4):349-81. PubMed ID: 17826946
[TBL] [Abstract][Full Text] [Related]
4. Determining normal variability in a developmental neurotoxicity test: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Raffaele KC; Fisher JE; Hancock S; Hazelden K; Sobrian SK
Neurotoxicol Teratol; 2008; 30(4):288-325. PubMed ID: 18280700
[TBL] [Abstract][Full Text] [Related]
5. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Crofton KM; Foss JA; Hass U; Jensen KF; Levin ED; Parker SP
Neurotoxicol Teratol; 2008; 30(4):266-87. PubMed ID: 17681747
[TBL] [Abstract][Full Text] [Related]
6. Introduction to the ILSI Research Foundation/Risk Science Institute reports from the expert working group on neurodevelopmental endpoints.
Fitzpatrick J; Mendez E; Walls I
Neurotoxicol Teratol; 2008; 30(4):263-5. PubMed ID: 18407461
[TBL] [Abstract][Full Text] [Related]
7. Practical considerations on the design, execution and analysis of developmental neurotoxicity studies to be published in Neurotoxicology and Teratology.
Maurissen J
Neurotoxicol Teratol; 2010; 32(2):121-3. PubMed ID: 19755149
[TBL] [Abstract][Full Text] [Related]
8. The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A: implications for toxicity testing.
Beronius A; Johansson N; Rudén C; Hanberg A
Toxicology; 2013 Sep; 311(1-2):13-26. PubMed ID: 23485653
[TBL] [Abstract][Full Text] [Related]
9. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.
Moser VC; Walls I; Zoetis T
Int J Toxicol; 2005; 24(2):87-94. PubMed ID: 16036767
[TBL] [Abstract][Full Text] [Related]
10. Developmental neuropathology in DNT-studies--a sensitive tool for the detection and characterization of developmental neurotoxicants.
Kaufmann W; Gröters S
Reprod Toxicol; 2006 Aug; 22(2):196-213. PubMed ID: 16781841
[TBL] [Abstract][Full Text] [Related]
11. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
Hass U
Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
[TBL] [Abstract][Full Text] [Related]
12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
13. A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing--for today.
Bolon B; Garman R; Jensen K; Krinke G; Stuart B;
Toxicol Pathol; 2006; 34(3):296-313. PubMed ID: 16698729
[TBL] [Abstract][Full Text] [Related]
14. Power and sample size when multiple endpoints are considered.
Senn S; Bretz F
Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
[TBL] [Abstract][Full Text] [Related]
15. Current developments in reproductive toxicity testing of pesticides.
Cooper RL
Reprod Toxicol; 2009 Sep; 28(2):180-7. PubMed ID: 19409482
[TBL] [Abstract][Full Text] [Related]
16. Progressive statistics for studies in sports medicine and exercise science.
Hopkins WG; Marshall SW; Batterham AM; Hanin J
Med Sci Sports Exerc; 2009 Jan; 41(1):3-13. PubMed ID: 19092709
[TBL] [Abstract][Full Text] [Related]
17. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
[TBL] [Abstract][Full Text] [Related]
18. Behavioral test methods workshop.
Slikker W; Acuff K; Boyes WK; Chelonis J; Crofton KM; Dearlove GE; Li A; Moser VC; Newland C; Rossi J; Schantz S; Sette W; Sheets L; Stanton M; Tyl S; Sobotka TJ
Neurotoxicol Teratol; 2005; 27(3):417-27. PubMed ID: 15939202
[TBL] [Abstract][Full Text] [Related]
19. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
20. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: a case study of dimethoate.
DeSesso JM; Watson RE; Keen CL; Hazelden KP; Haws LC; Li AA
J Toxicol Environ Health A; 2009; 72(2):94-109. PubMed ID: 19034799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
